RSIFX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RSIFX Analyst Rating

Strong Buy

78 Buy

9 Hold

0 Sell

Based on the consensus analyst ratings on 87 stocks held in RSIFX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RSIFX Analyst Price Target

Average Price Target

$31.44

Based on 87 Wall Street analysts offering 12 month price targets to Victory RS Science and Technology Fund - Class A holdings in the last 3 months. The average price target is $31.44 with a high forecast of $39.79 and a low forecast of $23.03. The average price target represents a 34.59% change from the last price of $23.36.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"$21","40":"$40","25.75":"$25.8","30.5":"$30.5","35.25":"$35.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":39.785,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$39.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.441,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$31.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.031,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$23.03</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,25.75,30.5,35.25,40],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.33,27.365,28.4,29.435,30.47,31.505,32.54,33.574999999999996,34.61,35.644999999999996,36.68,37.714999999999996,38.75,{"y":39.785,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.33,26.723153846153846,27.11630769230769,27.509461538461537,27.902615384615384,28.295769230769228,28.688923076923075,29.082076923076922,29.47523076923077,29.868384615384613,30.26153846153846,30.654692307692308,31.04784615384615,{"y":31.441,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.33,26.07623076923077,25.822461538461535,25.568692307692306,25.314923076923076,25.061153846153843,24.807384615384613,24.553615384615384,24.299846153846154,24.04607692307692,23.79230769230769,23.538538461538458,23.28476923076923,{"y":23.031,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.21,"date":1717372800000,"info":"<div>Price: <b>$22<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.25,"date":1719792000000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.43,"date":1722470400000,"info":"<div>Price: <b>$22<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.16,"date":1725321600000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.24,"date":1727740800000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.21,"date":1730419200000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.1,"date":1733097600000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.24,"date":1735776000000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.77,"date":1738540800000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.43,"date":1740960000000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.96,"date":1743465600000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.03,"date":1746057600000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.33,"date":1748822400000,"info":"<div>Price: <b>$26<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$39.79

Average Price Target$31.44

Lowest Price Target$23.03

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

RSIFX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CAMP

CAMP4 Therapeutics Corporation

―

5 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GOSS

Gossamer Bio

―

5 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

OLMA

Olema Pharmaceuticals, Inc.

―

6 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CAN

Canaan Inc.

―

3 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DYN

Dyne Therapeutics, Inc.

―

13 Buy

1 Hold

0 Sell

Strong Buy

―

RSIFX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MXL

Maxlinear

―

3 Buy

5 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

NFLX

Netflix

―

29 Buy

9 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

LRCX

Lam Research Corp

―

19 Buy

4 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRDO

Credo Technology Group Holding Ltd.

―

11 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RSIFX Mutual Fund FAQ

What is RSIFX’s average 12-month price target, according to analysts?

Based on analyst ratings, Victory RS Science and Technology Fund - Class A’s 12-month average price target is 31.44.

What is RSIFX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for RSIFX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is RSIFX a Buy, Sell or Hold?

Victory RS Science and Technology Fund - Class A has a consensus rating of Strong Buy which is based on 78 buy ratings, 9 hold ratings and 0 sell ratings.

What is Victory RS Science and Technology Fund - Class A’s price target?

The average price target for Victory RS Science and Technology Fund - Class A is 31.44. This is based on 87 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $39.79 ,the lowest forecast is $23.03. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Victory RS Science and Technology Fund - Class A?

Victory RS Science and Technology Fund - Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 87 Wall Streets Analysts.

How can I buy shares of RSIFX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing